Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Zuckerman

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyPatricia Cane, Ian Chrystie, David Dunn, et al.
European Journal of Pediatrics|February 4, 2014
Genetic predisposition of RSV infection-related respiratory morbidity in preterm infantsSimon B Drysdale, Michael Prendergast, Mireia Alcazar, et al.
Critical Care Medicine|January 29, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the BedsideKate El Bouzidi, Tasneem Pirani, Carolina Rosadas, et al.
STAR Protocols|April 28, 2022
Homebrew: Protocol for glassmilk-based nucleic-acid extraction for SARS-CoV-2 diagnosticsRobert Page, Edward Scourfield, Mattia Ficarelli, et al.
Cell Reports Methods|March 9, 2022
Homebrew: An economical and sensitive glassmilk-based nucleic-acid extraction method for SARS-CoV-2 diagnosticsRobert Page, Edward Scourfield, Mattia Ficarelli, et al.
Plos Computational Biology|July 18, 2022
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2Jose M Jimenez-Guardeño, Ana Maria Ortega-Prieto, Borja Menendez Moreno, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12Jose M Jimenez-Guardeño, Ana Maria Ortega-Prieto, Borja Menendez Moreno, et al.
The Lancet. Infectious Diseases|October 19, 2010
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyJulia Granerod, Helen E Ambrose, Nicholas Ws Davies, et al.
BMJ Open|July 24, 2021
Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitisThomas Whitfield, Cristina Fernandez, Kelly Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyPatricia Cane, Ian Chrystie, David Dunn, et al.
European Journal of Pediatrics|February 4, 2014
Genetic predisposition of RSV infection-related respiratory morbidity in preterm infantsSimon B Drysdale, Michael Prendergast, Mireia Alcazar, et al.
Critical Care Medicine|January 29, 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the BedsideKate El Bouzidi, Tasneem Pirani, Carolina Rosadas, et al.
STAR Protocols|April 28, 2022
Homebrew: Protocol for glassmilk-based nucleic-acid extraction for SARS-CoV-2 diagnosticsRobert Page, Edward Scourfield, Mattia Ficarelli, et al.
Cell Reports Methods|March 9, 2022
Homebrew: An economical and sensitive glassmilk-based nucleic-acid extraction method for SARS-CoV-2 diagnosticsRobert Page, Edward Scourfield, Mattia Ficarelli, et al.
Plos Computational Biology|July 18, 2022
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2Jose M Jimenez-Guardeño, Ana Maria Ortega-Prieto, Borja Menendez Moreno, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12Jose M Jimenez-Guardeño, Ana Maria Ortega-Prieto, Borja Menendez Moreno, et al.
The Lancet. Infectious Diseases|October 19, 2010
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyJulia Granerod, Helen E Ambrose, Nicholas Ws Davies, et al.
BMJ Open|July 24, 2021
Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitisThomas Whitfield, Cristina Fernandez, Kelly Davies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Pageof 6